Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Stratec SE

Start price
Target price
Perf. (%)
€122.40
30.12.20
€128.00
30.12.21
12.75%
31.12.21

Could be worthwhile Investment >10% per year
buy
Kontron AG

Start price
Target price
Perf. (%)
€14.30
16.12.21
-
16.12.22
11.61%
27.12.21

Could be worthwhile Investment >10% per year
buy
Kontron AG

Start price
Target price
Perf. (%)
€14.30
16.12.21
-
16.12.22
11.61%
27.12.21

Could be worthwhile Investment >10% per year
buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€30.15
25.12.20
€50.00
25.12.21
104.98%
26.12.21

Could be worthwhile Investment >10% per year
buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€30.15
25.12.20
€50.00
25.12.21
104.98%
26.12.21

Could be worthwhile Investment >10% per year
buy
Nordex SE

Start price
Target price
Perf. (%)
€14.61
13.12.21
€16.30
13.12.22
-1.85%
25.12.21

Sustainability is important
Known brand
Very Future proof/growth oriented business model
Higher risks for its business
buy
Nordex SE

Start price
Target price
Perf. (%)
€14.61
13.12.21
€16.30
13.12.22
-1.85%
25.12.21

Sustainability is important
Known brand
Very Future proof/growth oriented business model
Higher risks for its business
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.26
12.12.21
-
12.12.22
9.82%
25.12.21

Could be very worthwhile Investment >20% year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€45.60
12.12.21
-
12.12.22
23.60%
25.12.21

Could be very worthwhile Investment >20% year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€3.32
12.12.21
-
12.12.22
2.65%
25.12.21

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€151.40
12.12.21
-
12.12.22
5.67%
25.12.21

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.66
12.12.21
-
12.12.22
-1.27%
25.12.21

Could be worthwhile Investment >10% per year
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.48
12.12.21
-
12.12.22
25.48%
25.12.21

Could be worthwhile Investment >10% per year
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.49
12.12.21
-
12.12.22
4.74%
25.12.21

Could be worthwhile Investment >10% per year
buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€3.49
21.12.21
-
21.12.22
7.56%
25.12.21

Risky Investment
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.70
12.12.21
-
12.12.22
-5.19%
25.12.21

Could be worthwhile Investment >10% per year
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.95
12.12.21
-
12.12.22
1.10%
25.12.21

Could be worthwhile Investment >10% per year
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€32.60
16.12.21
-
16.12.22
38.19%
25.12.21

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Nordex SE

Start price
Target price
Perf. (%)
€14.95
05.12.21
-
05.12.22
-5.42%
23.12.21

buy
Nordex SE

Start price
Target price
Perf. (%)
€14.95
05.12.21
-
05.12.22
-5.42%
23.12.21

Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€16.08
24.06.21
€4.80
24.06.22
-60.12%
20.12.21

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
buy
Canadian Solar Inc.

Start price
Target price
Perf. (%)
€34.19
27.06.21
€34.00
27.06.22
-21.21%
20.12.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€24.98
18.12.20
€140.00
18.12.21
3.28%
19.12.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group